Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Decreasing Total Medication Exposure and Length of Stay While Completing Withdrawal for Neonatal Abstinence Syndrome during the Neonatal Hospital Stay.

Devlin LA, Lau T, Radmacher PG.

Front Pediatr. 2017 Oct 10;5:216. doi: 10.3389/fped.2017.00216. eCollection 2017.

2.

Judging the Neonatal Abstinence Syndrome Assessment Tools to Guide Future Tool Development: The use of Clinimetrics as Opposed to Psychometrics.

Westgate PM, Gomez-Pomar E.

Front Pediatr. 2017 Sep 20;5:204. doi: 10.3389/fped.2017.00204. eCollection 2017. Review.

3.

Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA.

Gomez Pomar E, Finnegan LP, Devlin L, Bada H, Concina VA, Ibonia KT, Westgate PM.

BMJ Open. 2017 Sep 27;7(9):e016176. doi: 10.1136/bmjopen-2017-016176.

4.

Neonatal abstinence syndrome and early childhood morbidity and mortality in Washington state: a retrospective cohort study.

Witt CE, Rudd KE, Bhatraju P, Rivara FP, Hawes SE, Weiss NS.

J Perinatol. 2017 Oct;37(10):1124-1129. doi: 10.1038/jp.2017.106. Epub 2017 Jul 6.

PMID:
28682319
6.

An Initiative to Improve the Quality of Care of Infants With Neonatal Abstinence Syndrome.

Grossman MR, Berkwitt AK, Osborn RR, Xu Y, Esserman DA, Shapiro ED, Bizzarro MJ.

Pediatrics. 2017 Jun;139(6). pii: e20163360. doi: 10.1542/peds.2016-3360. Epub 2017 May 18.

PMID:
28562267
7.

In Utero Oxcarbazepine Exposure and Neonatal Abstinence Syndrome: Case Report and Brief Review of the Literature.

Chen CY, Li X, Ma LY, Wu PH, Zhou Y, Feng Q, Cui YM.

Pharmacotherapy. 2017 Jul;37(7):e71-e75. doi: 10.1002/phar.1955. Epub 2017 Jul 2.

8.

Addiction-25 Years Later.

Greenfield SF, Weiss RD.

Harv Rev Psychiatry. 2017 May/Jun;25(3):97-100. doi: 10.1097/HRP.0000000000000159. No abstract available.

PMID:
28475500
9.

Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.

Klaman SL, Isaacs K, Leopold A, Perpich J, Hayashi S, Vender J, Campopiano M, Jones HE.

J Addict Med. 2017 May/Jun;11(3):178-190. doi: 10.1097/ADM.0000000000000308.

10.

Prise en charge des troubles de consommation d’opioïdes en première ligne: Abstinence, méthadone ou buprénorphine-naloxone?

Srivastava A, Kahan M, Nader M.

Can Fam Physician. 2017 Mar;63(3):e153-e159. Review. French.

PMID:
28292811
Free PMC Article
11.

Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?

Srivastava A, Kahan M, Nader M.

Can Fam Physician. 2017 Mar;63(3):200-205. Review.

12.
13.

Maternal buprenorphine treatment and fetal neurobehavioral development.

Jansson LM, Velez M, McConnell K, Spencer N, Tuten M, Jones HE, King VL, Gandotra N, Milio LA, Voegtline K, DiPietro JA.

Am J Obstet Gynecol. 2017 May;216(5):529.e1-529.e8. doi: 10.1016/j.ajog.2017.01.040. Epub 2017 Feb 7.

PMID:
28188773
14.

P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine.

Liao MZ, Gao C, Shireman LM, Phillips B, Risler LJ, Neradugomma NK, Choudhari P, Prasad B, Shen DD, Mao Q.

Pharmacol Res. 2017 May;119:61-71. doi: 10.1016/j.phrs.2017.01.018. Epub 2017 Jan 19.

PMID:
28111265
15.

The comparative safety of buprenorphine versus methadone in pregnancy-what about confounding?

Brogly SB, Saia K, Hernández-Diaz S, Werler M, Sebastiani P.

Addiction. 2016 Dec;111(12):2130-2131. doi: 10.1111/add.13551. No abstract available.

16.

Association of maternal and infant variants in PNOC and COMT genes with neonatal abstinence syndrome severity.

Wachman EM, Hayes MJ, Sherva R, Brown MS, Shrestha H, Logan BA, Heller NA, Nielsen DA, Farrer LA.

Am J Addict. 2017 Jan;26(1):42-49. doi: 10.1111/ajad.12483. Epub 2016 Dec 16.

PMID:
27983768
17.

Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review.

Korthuis PT, McCarty D, Weimer M, Bougatsos C, Blazina I, Zakher B, Grusing S, Devine B, Chou R.

Ann Intern Med. 2017 Feb 21;166(4):268-278. doi: 10.7326/M16-2149. Epub 2016 Dec 6. Review.

18.

Wide Variation Found in Care of Opioid-Exposed Newborns.

Bogen DL, Whalen BL, Kair LR, Vining M, King BA.

Acad Pediatr. 2017 May - Jun;17(4):374-380. doi: 10.1016/j.acap.2016.10.003. Epub 2016 Nov 23.

PMID:
27889436
19.

Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population.

Jumah NA, Edwards C, Balfour-Boehm J, Loewen K, Dooley J, Gerber Finn L, Kelly L.

BMJ Open. 2016 Oct 31;6(10):e011774. doi: 10.1136/bmjopen-2016-011774.

20.

A Comparison of Morphine Delivery in Neonatal Opioid Withdrawal.

Chisamore B, Labana S, Blitz S, Ordean A.

Subst Abuse. 2016 Sep 26;10(Suppl 1):49-54. eCollection 2016.

Supplemental Content

Support Center